vs
Tonix Pharmaceuticals Holding Corp.（TNXP）与VALUE LINE INC（VALU）财务数据对比。点击上方公司名可切换其他公司
VALUE LINE INC的季度营收约是Tonix Pharmaceuticals Holding Corp.的1.5倍（$8.3M vs $5.4M），VALUE LINE INC净利率更高（71.4% vs -870.3%，领先941.7%），Tonix Pharmaceuticals Holding Corp.同比增速更快（108.8% vs -7.7%），过去两年Tonix Pharmaceuticals Holding Corp.的营收复合增速更高（47.4% vs -4.1%）
Tonix Pharmaceuticals是一家总部位于美国新泽西州查塔姆的制药企业，核心业务聚焦于中枢神经系统疾病适应症的再利用药物开发，截至2020年，该公司同时还在开展新冠疫苗研发以及一个生物防御相关项目。
价值线公司是一家总部位于纽约的上市投资研究与金融出版企业，由阿诺德·伯恩哈德于1931年创立。该公司最为人熟知的业务是出版《价值线投资调查》，这份股票分析刊物跟踪覆盖约1700只上市个股的行情与研究。
TNXP vs VALU — 直观对比
营收规模更大
VALU
是对方的1.5倍
$5.4M
营收增速更快
TNXP
高出116.5%
-7.7%
净利率更高
VALU
高出941.7%
-870.3%
两年增速更快
TNXP
近两年复合增速
-4.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $5.4M | $8.3M |
| 净利润 | $-46.9M | $5.9M |
| 毛利率 | 80.4% | — |
| 营业利润率 | -895.8% | 12.1% |
| 净利率 | -870.3% | 71.4% |
| 营收同比 | 108.8% | -7.7% |
| 净利润同比 | -112.2% | 14.5% |
| 每股收益（稀释后） | $-4.28 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收TNXPVALU
| Q1 26 | — | $8.3M | ||
| Q4 25 | $5.4M | $8.6M | ||
| Q3 25 | $3.3M | $8.6M | ||
| Q2 25 | $2.0M | $8.4M | ||
| Q1 25 | $2.4M | $9.0M | ||
| Q4 24 | $2.6M | $8.8M | ||
| Q3 24 | $2.8M | $8.9M | ||
| Q2 24 | $2.2M | $9.0M |
净利润TNXPVALU
| Q1 26 | — | $5.9M | ||
| Q4 25 | $-46.9M | $5.7M | ||
| Q3 25 | $-32.0M | $6.5M | ||
| Q2 25 | $-28.3M | $4.0M | ||
| Q1 25 | $-16.8M | $5.2M | ||
| Q4 24 | $-22.1M | $5.7M | ||
| Q3 24 | $-14.2M | $5.9M | ||
| Q2 24 | $-78.8M | $4.8M |
毛利率TNXPVALU
| Q1 26 | — | — | ||
| Q4 25 | 80.4% | — | ||
| Q3 25 | 58.4% | — | ||
| Q2 25 | -63.8% | — | ||
| Q1 25 | 61.2% | — | ||
| Q4 24 | 54.2% | — | ||
| Q3 24 | 44.9% | — | ||
| Q2 24 | -52.5% | — |
营业利润率TNXPVALU
| Q1 26 | — | 12.1% | ||
| Q4 25 | -895.8% | 17.7% | ||
| Q3 25 | -1005.1% | 17.4% | ||
| Q2 25 | -1416.2% | 9.9% | ||
| Q1 25 | -660.9% | 17.4% | ||
| Q4 24 | -870.6% | 19.7% | ||
| Q3 24 | -551.2% | 20.8% | ||
| Q2 24 | -3501.6% | 16.5% |
净利率TNXPVALU
| Q1 26 | — | 71.4% | ||
| Q4 25 | -870.3% | 66.4% | ||
| Q3 25 | -972.9% | 75.1% | ||
| Q2 25 | -1415.0% | 47.1% | ||
| Q1 25 | -692.8% | 57.6% | ||
| Q4 24 | -856.2% | 64.3% | ||
| Q3 24 | -503.6% | 66.3% | ||
| Q2 24 | -3567.8% | 53.1% |
每股收益（稀释后）TNXPVALU
| Q1 26 | — | — | ||
| Q4 25 | $-4.28 | — | ||
| Q3 25 | $-3.59 | — | ||
| Q2 25 | $-3.86 | — | ||
| Q1 25 | $-2.84 | — | ||
| Q4 24 | $2302.65 | — | ||
| Q3 24 | $-22.68 | — | ||
| Q2 24 | $-1920.85 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $207.6M | $92.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $245.2M | $107.8M |
| 总资产 | $277.2M | $151.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资TNXPVALU
| Q1 26 | — | $92.5M | ||
| Q4 25 | $207.6M | $86.6M | ||
| Q3 25 | $190.1M | $33.7M | ||
| Q2 25 | $125.3M | $67.7M | ||
| Q1 25 | $131.7M | $52.8M | ||
| Q4 24 | $98.8M | $22.3M | ||
| Q3 24 | $28.2M | $30.9M | ||
| Q2 24 | $4.2M | $4.4M |
总债务TNXPVALU
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $8.7M | — | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $10.1M | — |
股东权益TNXPVALU
| Q1 26 | — | $107.8M | ||
| Q4 25 | $245.2M | $105.5M | ||
| Q3 25 | $231.1M | $103.0M | ||
| Q2 25 | $168.0M | $99.7M | ||
| Q1 25 | $180.4M | $99.0M | ||
| Q4 24 | $139.6M | $96.7M | ||
| Q3 24 | $74.2M | $93.9M | ||
| Q2 24 | $42.1M | $90.8M |
总资产TNXPVALU
| Q1 26 | — | $151.0M | ||
| Q4 25 | $277.2M | $147.9M | ||
| Q3 25 | $252.4M | $148.2M | ||
| Q2 25 | $187.4M | $144.5M | ||
| Q1 25 | $192.9M | $143.6M | ||
| Q4 24 | $162.9M | $140.0M | ||
| Q3 24 | $95.0M | $138.6M | ||
| Q2 24 | $70.3M | $136.0M |
负债/权益比TNXPVALU
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.06× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.24× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-39.6M | $5.3M |
| 自由现金流经营现金流 - 资本支出 | $-41.5M | — |
| 自由现金流率自由现金流/营收 | -770.4% | — |
| 资本支出强度资本支出/营收 | 34.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | 0.89× |
| 过去12个月自由现金流最近4个季度 | $-103.2M | — |
8季度趋势，按日历期对齐
经营现金流TNXPVALU
| Q1 26 | — | $5.3M | ||
| Q4 25 | $-39.6M | $3.0M | ||
| Q3 25 | $-28.8M | $5.6M | ||
| Q2 25 | $-14.8M | $20.2M | ||
| Q1 25 | $-16.6M | $6.9M | ||
| Q4 24 | $-14.6M | $3.1M | ||
| Q3 24 | $-18.8M | $4.8M | ||
| Q2 24 | $-9.9M | $17.9M |
自由现金流TNXPVALU
| Q1 26 | — | — | ||
| Q4 25 | $-41.5M | — | ||
| Q3 25 | $-29.7M | — | ||
| Q2 25 | $-15.4M | $20.1M | ||
| Q1 25 | $-16.6M | $6.8M | ||
| Q4 24 | $-14.6M | $3.0M | ||
| Q3 24 | $-18.8M | $4.8M | ||
| Q2 24 | — | $17.9M |
自由现金流率TNXPVALU
| Q1 26 | — | — | ||
| Q4 25 | -770.4% | — | ||
| Q3 25 | -904.1% | — | ||
| Q2 25 | -768.8% | 239.2% | ||
| Q1 25 | -682.8% | 75.3% | ||
| Q4 24 | -566.7% | 34.1% | ||
| Q3 24 | -666.5% | 53.7% | ||
| Q2 24 | — | 199.0% |
资本支出强度TNXPVALU
| Q1 26 | — | 0.0% | ||
| Q4 25 | 34.8% | 0.0% | ||
| Q3 25 | 29.2% | 0.0% | ||
| Q2 25 | 26.4% | 2.1% | ||
| Q1 25 | 0.2% | 1.2% | ||
| Q4 24 | 0.1% | 0.7% | ||
| Q3 24 | 0.3% | 0.0% | ||
| Q2 24 | 0.0% | 0.2% |
现金转化率TNXPVALU
| Q1 26 | — | 0.89× | ||
| Q4 25 | — | 0.52× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 5.12× | ||
| Q1 25 | — | 1.33× | ||
| Q4 24 | — | 0.54× | ||
| Q3 24 | — | 0.81× | ||
| Q2 24 | — | 3.75× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
TNXP
| Zembrace Symtouch | $3.1M | 58% |
| Other | $2.3M | 42% |
VALU
暂无分部数据
